Canadian CANNAINVESTOR Magazine August / September 2017 - Page 210


- Receives regulatory (ANVISA) approval for Isoderm for the treatment of epilepsy and Parkinson's. SOURCE

- Other recent news including Mexico and Brazil. SOURCE FOR ALL NRs

- Video: Pure, Natural CBD | Isodiol

What is interesting is that even if one did not look into ISOL further based on being in CannaInvestor Magazine including its Stock Pick lists, this news release came out well before the official financials out but it was not until the latter date that the share price began its 100%+ climb in five days. As has been stated many times, always check for news releases daily from companies and sign up for their own email updates. Is there still tremendous upside potential for ISOL share price based on all the referenced factors OR will low cost shares start to impede that momentum when the holding period ends? The holding period ends in late August but only 1/12th of shares held can be sold on the secondary market per one-month anniversary thereafter. Time will tell but investors should look at the longer horizon overall and the shorter time horizon to time their entry and exit points.

Reviewing “short positions” should always be done as was emphasized in past articles such as this customized selection demonstrates: